A leading DTx co-dev partner.
Healthware Therapeutics' DTx partnerships are built upon an evolving pipeline of digital therapeutic solutions that give our partners an opportunity to jumpstart their digital health goals by licensing or co-investing in emerging DTx solutions. Our expertise is in core areas such as medical, technology, user design data and behavioral sciences, which contribute to our expanding DTx pipeline. Our assets consist of our proprietary DTx platform (H.Core), venture acquisitions and dynamic collaborations with innovative digital health startups.
Born and raised in Italy, then professionally baked in the US, Gerry Chillè is a unique multi-cultural individual with a polymorphous approach to problem solving and a true out-of-the-box thinker thanks to his extensive creative, technical and strategic background.
We are very excited to share the great results of the Orion Corporation Clinical Trial where Healthware was the key R&D partner creating a Digital Therapeutics solution (DTx) for chronic pain patients.
Some key takeaways from the webinar by Healthware Labs and Plexus Ventures
PME talks to Roberto Ascione, CEO of Healthware Group, Gualberto Gussoni, Scientific Director of FADOI, Scientific Society of Internal Medicine and Giuseppe Recchia, Director of Tendenze Nuove about the advancement of digital therapeutics in Italy